Cargando…

Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag-time and drug release

INTRODUCTION: A tablet system consisting of cores coated with two layers of swelling and rupturable coatings was prepared and evaluated as time controlled chronomodulated tablet. MATERIALS AND METHODS: Cores containing Montelukast sodium as model drug were prepared by direct compression and then coa...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Mayur, Jivani, Rishad R, Patel, Laxman D, Jivani, Noordin P, Sonagara, Bhavin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618637/
https://www.ncbi.nlm.nih.gov/pubmed/23580937
http://dx.doi.org/10.4103/2230-973X.107005
_version_ 1782265433437503488
author Desai, Mayur
Jivani, Rishad R
Patel, Laxman D
Jivani, Noordin P
Sonagara, Bhavin
author_facet Desai, Mayur
Jivani, Rishad R
Patel, Laxman D
Jivani, Noordin P
Sonagara, Bhavin
author_sort Desai, Mayur
collection PubMed
description INTRODUCTION: A tablet system consisting of cores coated with two layers of swelling and rupturable coatings was prepared and evaluated as time controlled chronomodulated tablet. MATERIALS AND METHODS: Cores containing Montelukast sodium as model drug were prepared by direct compression and then coated sequentially with an inner swelling layer containing a HPMC E 5 and an outer rupturable layer of Eudragit RL/RS (1:1). A three-factor, two-level, full factorial design was used to investigate the influence of amount of HPMC E 5 and Eudragit RL/RS (1:1) on the responses, i.e., lag time to release and time required for 80% of drug to releases. The dissolution tests were studied using the USP paddle method at 50 rpm in 0.1 N HCL for 2 hr and than in phosphate buffer pH 6.8. METHODS: Cores containing Montelukast sodium as model drug were prepared by direct compression and then coated sequentially with an inner swelling layer containing a HPMC E 5 and an outer rupturable layer of Eudragit RL/RS (1:1). A three-factor, two-level, full factorial design was used to investigate the influence of amount of HPMC E 5 and Eudragit RL/RS (1:1) on the responses, i.e., lag time to release and time required for 80% of drug to releases. The dissolution tests were studied using the USP paddle method at 50 rpm in 0.1 N HCL for 2 hr and than in phosphate buffer pH 6.8. RESULT: The lag time of the drug release decreased by increasing the inner swelling layer and increased by increasing the rupturing layer level. CONCLUSION: The results obtain from present study suggest that swelling come reputable coating approach gives desire drug release after lag time.
format Online
Article
Text
id pubmed-3618637
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36186372013-04-11 Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag-time and drug release Desai, Mayur Jivani, Rishad R Patel, Laxman D Jivani, Noordin P Sonagara, Bhavin Int J Pharm Investig Original Research Article INTRODUCTION: A tablet system consisting of cores coated with two layers of swelling and rupturable coatings was prepared and evaluated as time controlled chronomodulated tablet. MATERIALS AND METHODS: Cores containing Montelukast sodium as model drug were prepared by direct compression and then coated sequentially with an inner swelling layer containing a HPMC E 5 and an outer rupturable layer of Eudragit RL/RS (1:1). A three-factor, two-level, full factorial design was used to investigate the influence of amount of HPMC E 5 and Eudragit RL/RS (1:1) on the responses, i.e., lag time to release and time required for 80% of drug to releases. The dissolution tests were studied using the USP paddle method at 50 rpm in 0.1 N HCL for 2 hr and than in phosphate buffer pH 6.8. METHODS: Cores containing Montelukast sodium as model drug were prepared by direct compression and then coated sequentially with an inner swelling layer containing a HPMC E 5 and an outer rupturable layer of Eudragit RL/RS (1:1). A three-factor, two-level, full factorial design was used to investigate the influence of amount of HPMC E 5 and Eudragit RL/RS (1:1) on the responses, i.e., lag time to release and time required for 80% of drug to releases. The dissolution tests were studied using the USP paddle method at 50 rpm in 0.1 N HCL for 2 hr and than in phosphate buffer pH 6.8. RESULT: The lag time of the drug release decreased by increasing the inner swelling layer and increased by increasing the rupturing layer level. CONCLUSION: The results obtain from present study suggest that swelling come reputable coating approach gives desire drug release after lag time. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3618637/ /pubmed/23580937 http://dx.doi.org/10.4103/2230-973X.107005 Text en Copyright: © International Journal of Pharmaceutical Investigation http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Article
Desai, Mayur
Jivani, Rishad R
Patel, Laxman D
Jivani, Noordin P
Sonagara, Bhavin
Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag-time and drug release
title Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag-time and drug release
title_full Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag-time and drug release
title_fullStr Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag-time and drug release
title_full_unstemmed Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag-time and drug release
title_short Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag-time and drug release
title_sort development of time controlled chronomodulated tablet with swelling and rupturable layers: optimization of factors influencing lag-time and drug release
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618637/
https://www.ncbi.nlm.nih.gov/pubmed/23580937
http://dx.doi.org/10.4103/2230-973X.107005
work_keys_str_mv AT desaimayur developmentoftimecontrolledchronomodulatedtabletwithswellingandrupturablelayersoptimizationoffactorsinfluencinglagtimeanddrugrelease
AT jivanirishadr developmentoftimecontrolledchronomodulatedtabletwithswellingandrupturablelayersoptimizationoffactorsinfluencinglagtimeanddrugrelease
AT patellaxmand developmentoftimecontrolledchronomodulatedtabletwithswellingandrupturablelayersoptimizationoffactorsinfluencinglagtimeanddrugrelease
AT jivaninoordinp developmentoftimecontrolledchronomodulatedtabletwithswellingandrupturablelayersoptimizationoffactorsinfluencinglagtimeanddrugrelease
AT sonagarabhavin developmentoftimecontrolledchronomodulatedtabletwithswellingandrupturablelayersoptimizationoffactorsinfluencinglagtimeanddrugrelease